Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-06-07
1999-05-18
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
4353201, 435325, 435455, 530351, 514 44, A61K48/00
Patent
active
059049200
ABSTRACT:
A method of altering the specific, systemic immune response of an individual to a target antigen by the co-administration of a cytokine an adhesion or accessory molecule and the target antigen. The target antigen may be a tumor cell, a tumor cell antigen, an infectious agent or other foreign antigen, or other antigens to which an enhanced systemic immune response is desirable. Alternatively, the antigen may be a non-foreign antigen when a suppression of a systemic immune response is desired. The resulting systemic immune response is specific for the target antigen.
REFERENCES:
patent: 4931275 (1990-06-01), Shinitzky et al.
patent: 4963354 (1990-10-01), Shepard et al.
patent: 5078996 (1992-01-01), Conlon, III et al.
patent: 5098702 (1992-03-01), Zimmerman et al.
Mattei et al., Int. J. Cancer, 56:853-857, 1994.
Seigler et al., Annals of Surgery, 190(3):366-372, 1979.
Gilboa (Seminars in Oncology), vol. 23, 1: 101-107, 1996.
Mastrangelo et al., Seminars in Oncology, vol. 23, 1: 4-21, 1996.
Pardoll, TIPS, vol. 14: 202-208, 1993.
S.J. Russel, 1990, "Lymphokine Gene Therapy For Cancer," Immunology Today 11:196-200.
A.L. Asher et al., 1991, "Transduced with the Gene for Tumor Cells Transduced with the Gene for Tumor Necrosis Factor-Alpha. Evidence for Paracrine Immune Effects of Tumor Necrosis Factor Against Tumors," J. Immunol. 146:3227-3234.
E.R. Fearon et al., 1990, "Interleukin-2 Production by Tumor Cells bypasses T Helper Function in the Generation of an Antitumor Response," Cell 60:397-403.
P.T. Golumbek et al., 1991, "Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4," Science 254:713-716.
Rosenburg, 1988, Immun. Today 9(2):58-62.
Oettgen & Old, 1991, "The History of Cancer Immunotherapy", Biologic Therapy of Cancer Devita et al., Eds. (J. Lippincott Co.) pp. 87-119.
Asher, et. al., 1991, "Murine Tumor Cells Transduced With the Gene for Tumor Necrosis Factor-.alpha.", J. Immunol. 146: 3227-3234.
Havell, et al., 1988, "The Antitumor Function Of Tumor Necrosis Factor (TNF)", J. Exp. Med. 167: 1067-1085.
Gansbacher, et al., "Retroviral Vector-mediated .gamma.-Interferon Gene Transfer into Tumor Cells Generates Potent and Long Lasting Antitumor Immunity".
Forni, et al., 1988, "Helper strategy in tumor immunology: Expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy" Cancer and Met. Reviews 7:289-309.
Wantanabe, et al., 1989, "Exogenous expression of mouse interferon .gamma. cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity", Proc. Natl. Acad. Sci. USA 86:9456-9460.
Tepper, et al., 1989, "Murine Interleukin-4 Displays Potent Anti-Tumor Activity in Vivo", Cell 57: 503-512.
Fearon, et al., 1990, "Interleukin-2 Production by Tumor Cells Bypasses T Helper Function in the Generation of an Antitumor Response" Cell 60: 397-403.
Gansbacher, et al., 1990, "Interleukin 2 Gene Transfer into Tumor Cells Abrogates Tumorigenicity and Induces Protective Immunity" J. Exp. Med. 172: 1217-1224.
Blankenstein, et al., 1991, "Tumor suppression after Tumor Cell-targeted Necrosis Factor .alpha. Gene Transfer", J. Exp. Med. 173: 1047-1052.
Teng, et al., 1991, "Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity" Proc. Natl. Acad. Sci. USA 88: 3535-3539.
Colombo, et al., 1991, "Granulocyte Colony-stimulating Factor Gene Transfer Suppresses Tumorigenicity of a Murine Adenocarcinoma In Vivo" J. Exp. Med. 173: 889-897.
Rollins & Sunday, 1991, "Suppression of Tumor Formation In Vivo by Expression of the JE Gene in Malignant Cells", Mol. Cell Bio., 11: 3125-3131.
Hock, et al., 1991, "Interleukin 7 Induces CD4.sup.+ T Cell-dependent Tumor Rejection", J. Exp. Med. 174: 1291-1298.
Golumbek, et al., 1991, "Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4", Science 254: 713-716.
Foley, E.J., 1953, "Antigenic Properties of Methylcholanthrene-induced Tumors in Mice of the Strain of Origin", Cancer Res. 13: 835-837.
Klein, et al., 1960, "Demonstration of Resistance against Methylcholanthrene-induced Sarcomas in the Primary Autochthonous Host", Cancer Res. 20: 1561-1572.
Prehn & Main, 1957, "Immunity to Methylcholanthrene-Induced Sarcomas", J. Natl. Cancer Inst., 18: 769-778.
Revesz, Laszlo, 1960, "Detection of Antigenic Differences in Isologous Host-Tumor Systems by Pretreatment with Heavily Irradiated Tumor Cells", Cancer Res. 20: 443-451.
Korman, et al., 1987, Proc. Natl. Acad. Sci. USA, 84: 2150-2154.
Clerici, et al., 1991, "Detection of Cytotoxic T Lymphocytes Specific For Synthetic Peptides of gp160 In HIV-Seropositive Individuals", J. Immunol. 146: 2214-2219.
Venet, et al., 1992, "Cytotoxic T. Lymphocyte Response Against Multiple Simian Immunodeficiency Virus .sup.A (SIV) Proteins in SIV-Infected Macaques", J. Immunol. 148: 2899-2908.
Hosmalin, et al., 1991, "Priming With T Helper Cell Epitope Peptides Enhances The Antibody Response To The Envelope Glycoprotein of HIV-1 In Primates", J. Immunol. 146: 1667-1673.
Armentano, et al., 1987, "Effect of Internal Viral Sequences on the Utility of Retroviral Vectors", J. Virol. 61: 1647-1650.
Sanger, et al., 1977, "DNA sequencing with chain-terminating inhibitors" Proc. Natl. Acad. Sci. USA 74: 5463-5467.
Yokota, et al., 1985, "Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: Expression of T-cell growth-factor activity after transfection of monkey cells", Proc. Natl. Acad. Sci. USA 82: 68-72.
Lee, et al., 1986, "Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities", Proc. Natl. Acad. Sci. USA 83: 2061-2065.
Campbell, et al., 1988, "Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor", Eur. J. Biochem. 174: 345-353.
Gough, et al., 1985, "Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor", The EMBO Journal 4: 645-653.
Horley, et al., 1989, "Molecular cloning of murine intercellular adhesion molecule (ICAM-1)", The EMBO Journal 8: 2889-2896.
Yagita, et al., 1988, "Molecular Cloning of the Murine Homologue of CD2", J. Immunol. 140: 1321-1326.
Wang, et al., 1985, "Molecular Cloning of the Complementary DNA For Human Tumor Necrosis Factor", Science 228: 149-154.
Gearing, et al., 1987, "Production and assay of interleukin 2", Lymphokines and Interferons: a Practical Approach Clemens, et al., Eds. (IRL Press, Oxford) pp. 296-299.
Hu-Li, et al., 1989, "Derivation of a T Cell Line That Is Highly Responsive to IL-4 And II-2 (CT.4R) And Of An IL-2 Hyporesponsive Mutant Of That Line (CT.4S)", J. Immunol. 142: 800-807.
Le, et al., 1988, "Tumor Necrosis Factor and Interleukin 1 Can Act as Essential Growth Factors in a Murine Plasmacytoma Line", Lymphokine Research 7: 99-106.
Dexter, et al., 1980, "Growth of Factor-Dependent Hemopoietic Precursor Cell Lines", J. Exp. Med. 152: 1036-1047.
Dahl & Degre, 1972, "A Micro Assay For Mouse And Human Interferon", Acta. Pathol. Microbiol. Immunol. Scand. 80: 863-870.
Oliff, et al., 1987, "Tumors Secreting Human TNF/Cachectin Induce Cachexia In Mice", Cell, 50: 555-563.
Hannum, et al., 1990, "Interleukin-1 receptor antagonist activity of an human interleukin-1 inhibitor", Nature 343: 336-340.
Takei, Fumio 1985, "Inhibition of Mixed Lymphocyte Response By A Rat Monoclonal Antibody To A Novel Murine Lymphocyte Activation Antigen (MALA-2)", J. Immunol. 134: 1403-1407.
Danos & Mulligan, 1988, "Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges", Proc. Natl. Acad. Sci. USA 85: 6460-6464.
Parker & Stark, 1979, "Regulation of Simian Virus 40 Transcription: Sensitive Analysis of the RNA Species Present Early in Infections by Virus or Viral DNA", J. Virol. 31: 360-369 360-369.
Southern & Berg, 1975, "Transformation of Mammalian Cells to Antibiotic Resistance with a Bacterial Gene Under control of the SV40 Early R
Dranoff Glenn
Mulligan Richard C.
Pardoll Drew
Campell Bruce R.
Johns Hopkins University School of Medicine
Nguyen Dave Trong
Whitehead Institute for Biomedical Research
LandOfFree
Regulation of systemic immune responses utilizing cytokines and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of systemic immune responses utilizing cytokines and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of systemic immune responses utilizing cytokines and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1758545